{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:01:02Z","timestamp":1787169662439,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Severe acute respiratory syndrome coronavirus 2 infection has resulted in a pandemic, the disease manifests itself as various conditions ranging from respiratory disorders to exacerbated inflammatory responses. The management in some cases involves immediate care in an intensive setup with the administration of various antibiotics and steroids which has resulted in the imposition of risk factors and growth of fulminant fungal infection. The present article addresses two such cases which presented with osteomyelitis secondary to mucormycosis in patients who had more than one episode of COVID-19 infection. The upsurge of existing manifestation and development of opportunistic infections has to be considered in patients who are suffering or recovering from COVID-19. The COVID-19 scenario brings up a possibility of many bacterial and fungal infections in its aftermath. This article brings out two such opportunistic aggressive fungal infections and comprehensive management of the same.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njms.njms_289_20","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T03:40:37Z","timestamp":1681098037000},"page":"S153-S158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mucormycosis coinfection post-COVID-19 recovery"],"prefix":"10.4103","volume":"13","author":[{"given":"Vishal","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Senthil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CS","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20240908","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00428-020-02886-6","article-title":"Pulmonary pathology and COVID-19: Lessons from autopsy. The experience of European Pulmonary Pathologists","volume":"477","author":"Calabrese","year":"2020","journal-title":"Virchows Arch"},{"key":"R2-27-20240908","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R3-27-20240908","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R4-27-20240908","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmi.2014.07.013","article-title":"Burden of serious fungal infections in Spain","volume":"21","author":"Rodriguez-Tudela","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R5-27-20240908","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0161-6420(83)80052-9","article-title":"Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases","volume":"90","author":"Ferry","year":"1983","journal-title":"Ophthalmology"},{"key":"R6-27-20240908","first-page":"127","article-title":"Mucormycosis \u2013 Early diagnosis and treatment","volume":"125","author":"Guevara","year":"2004","journal-title":"Rev Laryngol Otol Rhinol (Bord"},{"key":"R7-27-20240908","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0149-2918(03)80125-X","article-title":"A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations","volume":"25","author":"Barrett","year":"2003","journal-title":"Clin Ther"},{"key":"R8-27-20240908","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: Summary of a report of 72 314 cases from the Chinese Center for Disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"R9-27-20240908","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/mmy\/myx066","article-title":"Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative","volume":"56","author":"Chindamporn","year":"2018","journal-title":"Med Mycol"},{"key":"R10-27-20240908","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R12-27-20240908","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0030-4220(93)90170-9","article-title":"Mucormycosis of the oral cavity","volume":"75","author":"Jones","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R13-27-20240908","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/0030-4220(69)90152-2","article-title":"Mucormycosis (phycomycosis) involving the maxilla. Report of a case with survival","volume":"27","author":"Taylor","year":"1969","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R14-27-20240908","first-page":"705","article-title":"Successful treatment of mucocutaneous mucormycosis after dental extractions in a patient with uncontrolled diabetes","volume":"33","author":"Limongelli","year":"1975","journal-title":"J Oral Surg"},{"key":"R15-27-20240908","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/ams.ams_23_16","article-title":"Mucormycosis of the Frontal Sinus: A Rare Case Report and Review","volume":"7","author":"Sahoo","year":"2017","journal-title":"Ann Maxillofac Surg"},{"key":"R16-27-20240908","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jgar.2020.10.004","article-title":"Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming \u201ccollateral effect\u201d","volume":"23","author":"Cataldo","year":"2020","journal-title":"J Glob Antimicrob Resist"}],"container-title":["National Journal of Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njms.NJMS_289_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:43Z","timestamp":1787166703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njms.NJMS_289_20"}},"subtitle":["Early suspicion and prompt action"],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":15,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/njms.njms_289_20","relation":{},"ISSN":["0975-5950"],"issn-type":[{"value":"0975-5950","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}